Carin Uyl-de Groot (1966) is Professor of Health Technology Assessment at the Erasmus University Rotterdam, the Netherlands.
She is head of the department of Health Economics of the institute of Health Policy & Management and director of the institute for Medical Technology Assessment (iMTA). She has been program leader of cancer studies at the iMTA since 1994.
Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Her main interests consist of diagnostic and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She has also been involved in the development of clinical practice guidelines. Carin is principal investigator of several cancer registries and outcomes studies.
She is supervisor of many PhD students and serves as a reviewer for several (high impact) journals, including Lancet Oncology and Blood. She has presented her research in a variety of clinical and health economic journals and conferences.
Social Media Sharing
Subscribe our Newsletter
AEGLE platform is an innovative data analytics solution for your organization.